Dr. Fabian Pitter Steinmetz studied process engineering at the Umwelt-Campus Birkenfeld (Germany) and toxicology at the Athlone Institute of Technology (Ireland). After gaining experience in the biopharmaceutical industry, he obtained a PhD in predictive toxicology from Liverpool John Moores University (UK). He works at the international consultancy Delphic HSE since early 2016, interrupted by a post-doc at Merck KGaA in the area of drug design. Steinmetz has (co-)authored over 200 safety assessments, expert opinions and scientific publications. Also, he is a European Registered Toxicologist (ERT) since early 2020 and he supports an evidence-based drug policy reform via multiple NGO activities, e.g. at the German expert network Schildower Kreis.